CervoMed Inc. 8-K

What Happened

• CervoMed Inc. (CRVO) filed a Form 8‑K on June 15, 2026 (Item 7.01) to disclose an investor presentation now available at www.cervomed.com under "Investors – Events and Presentations." The presentation covers the business, clinical studies, development plans and the company’s financial position. Company representatives may use the presentation, in whole or in part, at investor conferences and meetings.

Key Details

• Filing date: June 15, 2026 (Form 8‑K, Item 7.01 — Regulation FD Disclosure).
• Presentation posted at: www.cervomed.com → Investors – Events and Presentations.
• Content scope: summary information on business, clinical studies, development plans and financial position; may be used periodically with non‑material modifications.
• Company statement: no obligation to update the presentation publicly except as required by law; the presentation is meant to be considered alongside SEC filings and other public disclosures.

Why It Matters

• This is a regulatory disclosure of investor materials (Reg FD), not a standalone earnings or clinical result filing. Investors should review the posted presentation for the company’s latest high‑level messaging about strategy, clinical programs and financial position, but rely on formal SEC filings for definitive financial or material disclosures. The posting can influence investor awareness and should be read in context with CervoMed’s other public filings.